BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 2053771)

  • 1. Interference of 7-hydroxymethotrexate with the determination of methotrexate in plasma samples from children with acute lymphoblastic leukemia employing routine clinical assays.
    Fotoohi K; Skärby T; Söderhäll S; Peterson C; Albertioni F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):139-44. PubMed ID: 15686977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
    Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
    Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate and 7-hydroxymethotrexate: serum level monitoring by high-performance liquid chromatography.
    Canfell C; Sadée W
    Cancer Treat Rep; 1980 Jan; 64(1):165-9. PubMed ID: 7379052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of serum methotrexate and 7-hydroxymethotrexate concentrations. Method evaluation showing advantages of high-performance liquid chromatography.
    So N; Chandra DP; Alexander IS; Webster VJ; O'Gorman Hughes DW
    J Chromatogr; 1985 Jan; 337(1):81-90. PubMed ID: 3884642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
    Chen ML; McGuire WP; Lad TE; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):1-6. PubMed ID: 6698654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatographic methods for the therapeutic drug monitoring of methotrexate as clinical decision support for personalized medicine: A brief review.
    Silva MF; Ribeiro C; Gonçalves VMF; Tiritan ME; Lima Á
    Biomed Chromatogr; 2018 May; 32(5):e4159. PubMed ID: 29226354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical methodologies for determination of methotrexate and its metabolites in pharmaceutical, biological and environmental samples.
    Karami F; Ranjbar S; Ghasemi Y; Negahdaripour M
    J Pharm Anal; 2019 Dec; 9(6):373-391. PubMed ID: 31890337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum monitoring of methotrexate (MTX) and 7-hydroxymethotrexate concentrations in patients treated with MTX using high-pressure liquid chromatography (HPLC) and comparison of serum MTX levels between HPLC method and fluorescence polarization immunoassay (FPIA)].
    Sakamoto S; Matsuhisa T; Miyoshi K; Naruse R; Urayama H; Shimokawa T; Okabe K; Toki H; Motoi M; Moriwaki S
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1119-25. PubMed ID: 2053771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo methotrexate kinetics and metabolism in human hematopoietic cells. Clinical significance of methotrexate concentrations in erythrocytes.
    Schrøder H
    Dan Med Bull; 1990 Feb; 37(1):22-40. PubMed ID: 2178886
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.